|
|
| |
Intermediate |
Structure |
CAS No. |
Usage |
| |
3-Ethynylailine |
|
54060-30-9 |
Erlotinib |
| |
1,2,3-tri-O-acetyl-5-deoxy ribofuranose |
|
62211-93-2 |
Capecitabine |
| |
2-deoxy-2,2-difluoro-d-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate |
|
122111-11-9 |
Gemcitabine Hydrochloride |
| |
2-Deoxy-2,2-difluoropentofuranos-1-ulose-3,5-dibenzoate |
|
122111-01-7 |
Gemcitabine Hydrochloride |
| |
4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile |
|
675126-26-8 |
Gefitinib |
| |
4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol |
|
184475-71-6 |
Gefitinib |
| |
4-(3-chloro-4-fluorophenylamino)-6-Acetoxy -7-methoxyquinazoline |
|
184475-70-5 |
Gefitinib |
| |
6-Acetoxy-4-chloro-7-methoxyquinazoline |
|
230955-75-6 |
Gefitinib |
| |
(3R,4S)-3-(1-Ethoxyethoxy)-4-(phenyl)-N-Benzoyl-2-Azetidinone |
|
201856-53-3 |
Paclitaxel |
| |
6-hydroxy-7-methoxyquinazolin-4(3H)-one |
|
179688-52-9 |
Gefitinib |
| |
(3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone |
|
132127-34-5 |
Paclitaxel |
| |
6,7-Bis(2-Methoxyethoxy) -4-Chloro-Quinazoline |
|
183377-18-1 |
Erlotinib |
| |
6,7-Bis(2-Methoxyethoxy) -4-(3H)-Quinazoline |
|
179688-29-0 |
Erlotinib |
| |
4,6-Dichloro-2-methylpyrimidine |
|
1780-26-3 |
Dasatinib |
| |
2-amino-n-(2-chloro-6-methylphenyl)thiazole-5-carboxamide |
|
302964-24-5 |
Dasatinib |
| |
4-[(4-Methyl-1-piperazinyl)methyl]-benzoic acid dihydrochloride |
|
106261-49-8 |
Imatinib Mesylate |
| |
4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine |
|
152460-10-1 |
Imatinib Mesylate |
| |
2',3'-di-O-acetyl-5'deoxy-5-fluorocytidine |
|
161599-46-8 |
Capecitabine |
| |
3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate |
|
179688-53-0 |
Gefitinib |
| |
Methyl-2,3-isopropylidene-5-o-p- toluene sulfonyl-b-D-ribofuranoside |
|
13007-50-6 |
Capecitabine |
| |
(1S,2S,3R,5S)-Pinanediol L-phenylalanine-L-leucine boronate, HCl salt |
|
N/A |
Bortezomid |
| |
(1R)-(S)- Pinanediol 1-ammonium trifluoroacetate-3-mrthylbutane-1-boronate |
|
179324-87-9 |
Bortezomid |
| |
Calcium folinate |
|
1492-18-8 |
Calcium |
| |
5-Amino-1-(N-methylcarbamoyl) imidazole-4-carboxamide |
|
188612-53-5 |
Temozolomide |
| |
3-Aminopiperidine-2,6-dione hydrochloride |
|
24666-56-6 |
Lenalidomide |
| |
Methyl 2-bromomethyl-3-nitrobenzoate |
|
98475-07-1 |
Lenalidomide |
| |
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt |
|
137281-23-3 |
Pemetrexed disodium |
| |
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate |
|
134790-39-9 |
Gemcitabine Hydrochloride |
| |
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate |
|
165049-28-5 |
Pemetrexed disodium |
| |
Bortezomib Intermediate |
|
N/A |
Bortezomid |
| |
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester |
|
146943-43-3 |
Pemetrexed disodium |
| |
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid |
|
137281-39-1 |
Pemetrexed disodium |
| |
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid methyl ester |
|
155405-80-4 |
Pemetrexed disodium |
| |
(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-(triethylsilyloxy)azetidine-1-carboxylate |
|
149198-47-0 |
Cabazitaxel |
| |
Benzeneprpanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)- |
|
114915-14-9 |
Docetaxel |
| |
2-Azetidinone,4-phenyl-3-[(triethylsilyl)oxy]-, (3R,4S)- |
|
149140-54-5 |
Docetaxel |
| |
(3R,4S)-1-Benzoyl-4-phenyl-3-[(triethylsilyl)oxy]-2-azetidinone |
|
149249-91-2 |
Paclitaxel |
| |
Methyl-5-deoxy-2,3-O-isopropylidene-beta-D-ribofuranoside |
|
23202-81-5 |
Capecitabine |
|
|
